Preventing suicide: A multicausal model requires multimodal research and intervention
- PMID: 29729077
- PMCID: PMC6175633
- DOI: 10.1111/bdi.12656
Preventing suicide: A multicausal model requires multimodal research and intervention
Conflict of interest statement
Dr. Zarate is listed as a co-inventor on a patent application for the use of ketamine and its metabolites in major depression. Dr. Zarate has assigned his rights in the patent to the U.S. Government but will share a percentage of any royalties that may be received by the Government. The remaining authors have no conflicts of interest to disclose, financial or otherwise.
Comment in
-
A parsimonious approach to suicide prevention in mood disorders.Bipolar Disord. 2018 Sep;20(6):570. doi: 10.1111/bdi.12688. Epub 2018 Jul 29. Bipolar Disord. 2018. PMID: 30058299 No abstract available.
Comment on
-
Modeling suicide in bipolar disorders.Bipolar Disord. 2018 Jun;20(4):334-348. doi: 10.1111/bdi.12622. Epub 2018 Feb 19. Bipolar Disord. 2018. PMID: 29457330 Review.
References
-
- Curtin SCWM, Hedegaard H. Increase in suicide in the United States, 1999–2014. Hyattsville, MD: 2016. - PubMed
-
- Grunebaum MF, Ellis SP, Keilp JG, et al. Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial. Bipolar Disord. 2017;19(3):176–183. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical